Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Change in Cash (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Change in Cash for 9 consecutive years, with -$8.0 million as the latest value for Q4 2025.

  • Quarterly Change in Cash fell 404.47% to -$8.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$45.3 million through Dec 2025, down 28.12% year-over-year, with the annual reading at -$45.3 million for FY2025, 28.12% down from the prior year.
  • Change in Cash hit -$8.0 million in Q4 2025 for Inspire Medical Systems, down from $5.9 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $231.2 million in Q3 2022 to a low of -$144.4 million in Q4 2023.
  • Historically, Change in Cash has averaged -$4.3 million across 5 years, with a median of -$2.6 million in 2021.
  • Biggest five-year swings in Change in Cash: surged 587.0% in 2022 and later crashed 1974.26% in 2024.
  • Year by year, Change in Cash stood at $4.3 million in 2021, then skyrocketed by 457.39% to $23.8 million in 2022, then crashed by 706.96% to -$144.4 million in 2023, then soared by 101.83% to $2.6 million in 2024, then plummeted by 404.47% to -$8.0 million in 2025.
  • Business Quant data shows Change in Cash for INSP at -$8.0 million in Q4 2025, $5.9 million in Q3 2025, and $53.0 million in Q2 2025.